Condition
Serous Cystadenoma
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting1
Terminated1
Completed1
Active Not Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07463872Recruiting
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
NCT03305146Not ApplicableActive Not Recruiting
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
NCT02523170Not ApplicableCompleted
A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas
NCT02494388Terminated
Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions
Showing all 4 trials